Related Experiment Video
Updated: May 13, 2026

Stereological and Flow Cytometry Characterization of Leukocyte Subpopulations in Models of Transient or Permanent Cerebral Ischemia
Published on: December 28, 2014
IL-6 and stroke recurrence in ischemic stroke
1Spine Center, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
Insights
Interleukin-6 (IL-6) shows promise as a biomarker for predicting stroke recurrence in patients with acute ischemic stroke. Higher IL-6 levels correlate with an increased risk of recurrent stroke events.
Area of Science:
- Neurology
- Biomarkers
- Inflammation
Background:
- Stroke recurrence poses a significant risk to patient outcomes.
- Identifying reliable predictive biomarkers is crucial for secondary stroke prevention.
Purpose of the Study:
- To assess the predictive capability of serum Interleukin-6 (IL-6) levels for stroke recurrence.
- To investigate the association between IL-6 and recurrent ischemic stroke events.
Main Methods:
- Prospective evaluation of 305 patients admitted within 48 hours of acute ischemic stroke onset.
- Serum IL-6 levels measured at admission.
- Stroke recurrence assessed at 3-month follow-up.
Main Results:
- 15.4% of patients experienced stroke recurrence within 3 months.
- Each 1 pg/ml increase in serum IL-6 was associated with an 8% increased risk of recurrence (OR: 1.08, 95% CI: 1.04-1.11).
- This association remained significant after adjusting for other factors (OR: 1.06, 95% CI: 1.02-1.10).
Conclusions:
- Serum IL-6 is a valuable predictive biomarker for identifying patients at higher risk of stroke recurrence.
- IL-6 measurement upon admission may aid in clinical decision-making for secondary stroke prevention.
Abstract:
Objective: This study aimed to evaluate the predictive value of IL-6 for stroke recurrence in acute ischemic stroke.Methods: Patients who were admitted within 48 h of onset were included. At 3-month, stroke recurrence was assessed. IL-6 levels were measured in serum samples taken upon admission.Results: Out of the 305 patients, 47 (15.4%) experienced a stroke recurrence. The risk of stroke recurrence increased by 8% (OR: 1.08; 95% CI: 1.04-1.11; p < 0.001) for every 1 pg/ml increase in IL-6 serum level, both in unadjusted and adjusted analyses (6%; OR: 1.06; 95% CI: 1.02-1.10; p = 0.001).Conclusion: The study supports the usefulness of IL-6 as a predictive biomarker for stroke recurrence after acute ischemic stroke.
Related Concept Videos
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

